Toronto Dominion Bank’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-200,000
Closed -$21.1M 2298
2025
Q4
$21.1M Buy
+200,000
New +$18.8M 0.03% 438
2019
Q4
Sell
-23,685
Closed -$1.9M 1477
2019
Q3
$1.9M Buy
+23,685
New +$1.9M ﹤0.01% 832
2019
Q1
Sell
-115,280
Closed -$8.4M 1675
2018
Q4
$8.4M Buy
115,280
+10,480
+10% +$740K 0.01% 469
2018
Q3
$7.09M Buy
+104,800
New +$6.68M 0.01% 595
2016
Q1
Sell
-45,064
Closed -$2.27M 1263
2015
Q4
$2.27M Buy
45,064
+28,296
+169% +$1.43M 0.01% 223
2015
Q3
$790K Sell
16,768
-4,192
-20% -$223K ﹤0.01% 388
2015
Q2
$1.14M Buy
20,960
+10,480
+100% +$588K 0.01% 365
2015
Q1
$575K Buy
+10,480
New +$593K ﹤0.01% 496

Other funds holding MRK

Toronto Dominion Bank's MRK Position: Q1 2026 in Review

Toronto Dominion Bank reduced its Merck (MRK) stake by 14% in Q1 2026, selling an estimated $18.5M and leaving 961,055 shares worth $116M. The position accounts for 0.17% of the portfolio, ranked #112.

Toronto Dominion Bank first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $480M in Q4 2019. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Toronto Dominion Bank held 961,055 shares of Merck worth $116M as of Q1 2026.
  • Toronto Dominion Bank sold 160,593 Merck shares in Q1 2026, an estimated $18.5M.
  • Merck made up 0.17% of Toronto Dominion Bank's portfolio in Q1 2026, its #112 holding.
  • Toronto Dominion Bank first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Toronto Dominion Bank's Merck position peaked at $480M in Q4 2019.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.